NHL

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

NHL

Sep 5, 2024, 11:17 | Blog

PentixaFor by Pentixapharm AG receives Orphan Drug Designation for Marginal Zone Lymphoma from the EMA

Pentixapharm Holding AG, the future holding company of Pentixapharm AG, a clinical-stage biotech company discovering…

Jul 29, 2024, 02:16 | Insight

Shahrin Ahmed: A significant increase in the number of clinical trials on Non-Hodgkin's lymphoma since 2019

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "In 2019,…

Jul 2, 2024, 04:51 | Insight

Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH

ASH shared a post on X: "A new study in Blood Advances find that patients…

Jun 12, 2024, 22:50 | Blog

Hockey Fights Cancer extends beyond the post-season - National Hockey League

National Hockey League shared on LinkedIn: "Hockey Fights Cancer extends beyond the post-season. The NHL…

All: 4 Posts: 1 - 100

'

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

Karen Knudsen: Clinical trials are the most advanced form of cancer care

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023